Search - tctmd.com

Displaying 121 - 140 of 140

Sort: Relevancy | Date

News Conference News AHA 2019

ISCHEMIA-CKD: Routine Invasive Approach No Help in CKD Patients With Stable CAD

Todd Neale

November 16, 2019

News Opinion Off Script AHA 2019

Off Script: Will ISCHEMIA Answer Our Most Pressing Questions?

Ajay Kirtane, MD, SM

November 12, 2019

News Daily News

For Percutaneous LVADs, Vascular Complications Decreasing but Still Common

Caitlin E. Cox

November 06, 2019

News Daily News

Better Survival 3 Years After TAVR for Patients With Mixed Aortic Valve Disease

L.A. McKeown

November 01, 2019

News Daily News

Elderly Women Worse Off Than Men Before and After Acute MI

Yael L. Maxwell

October 22, 2019

News Daily News

Implantable Cardiac Monitor May Reduce Delays to Hospital in High-Risk ACS

L.A. McKeown

October 15, 2019

News Conference News TCT 2019

New COMPLETE Data Affirm Benefit of Nonculprit PCI in STEMI Regardless of Timing

Todd Neale

September 28, 2019

News Opinion Editor's Corner TCT 2019

TCT 2019 Day Two: Transcatheter Valves, New and Old

Shelley Wood

September 27, 2019

News Conference News ESC 2019

COMPLETE Beats Culprit-Only PCI in Multivessel STEMI and Timing Doesn’t Matter

Yael L. Maxwell

September 01, 2019

News Daily News

Substantial Increase in PCI Survival Over 10 Years: Single Center

Yael L. Maxwell

August 16, 2019

News Daily News

FDA Grants Cardiac MR Indication for Gadavist Contrast Injection

Shelley Wood

July 16, 2019

News Conference News EuroPCR 2019

Small Study Lends Further Support to the Antiarrhythmic Potential of Renal Denervation

L.A. McKeown

June 06, 2019

News Daily News

Renal Denervation Lowers BP in Sham-Controlled Studies: Meta-Analysis

Michael O'Riordan

April 02, 2019

News Daily News

CMS Coverage Plan Keeps Volume Requirements for Existing TAVR Programs but Lowers Bar for New Centers

Michael O'Riordan

March 27, 2019

News Daily News

Industry, Investigators Push Back With Patient-Level Data Showing No Increased Death From Paclitaxel-Based PAD Therapies

L.A. McKeown

January 23, 2019

News Daily News

None of the Usual Suspects? Troponin Elevation Still Warrants Attention

Shelley Wood

January 11, 2019

News Daily News

Cancer Patients Should Not Be Automatically Ruled Out for TAVR: Analysis

L.A. McKeown

January 10, 2019

News Daily News

Treating to New Blood Pressure Goals Could Prevent Millions of CVD Events

L.A. McKeown

November 21, 2018

News Daily News

Mortality Outcomes Similar Whether TAVR Performed in Hybrid OR or Cath Lab

Yael L. Maxwell

November 14, 2018

News Conference News TCT 2018

PORTICO I: Low 1-Year Mortality With Repositionable TAVR Valve in OUS Experience

L.A. McKeown

September 27, 2018

Advertisement

ISCHEMIA-CKD: Routine Invasive Approach No Help in CKD Patients With Stable CAD

Off Script: Will ISCHEMIA Answer Our Most Pressing Questions?

For Percutaneous LVADs, Vascular Complications Decreasing but Still Common

Better Survival 3 Years After TAVR for Patients With Mixed Aortic Valve Disease

Elderly Women Worse Off Than Men Before and After Acute MI

Implantable Cardiac Monitor May Reduce Delays to Hospital in High-Risk ACS

New COMPLETE Data Affirm Benefit of Nonculprit PCI in STEMI Regardless of Timing

TCT 2019 Day Two: Transcatheter Valves, New and Old

COMPLETE Beats Culprit-Only PCI in Multivessel STEMI and Timing Doesn’t Matter

Substantial Increase in PCI Survival Over 10 Years: Single Center

FDA Grants Cardiac MR Indication for Gadavist Contrast Injection

Small Study Lends Further Support to the Antiarrhythmic Potential of Renal Denervation

Renal Denervation Lowers BP in Sham-Controlled Studies: Meta-Analysis

CMS Coverage Plan Keeps Volume Requirements for Existing TAVR Programs but Lowers Bar for New Centers

Industry, Investigators Push Back With Patient-Level Data Showing No Increased Death From Paclitaxel-Based PAD Therapies

None of the Usual Suspects? Troponin Elevation Still Warrants Attention

Cancer Patients Should Not Be Automatically Ruled Out for TAVR: Analysis

Treating to New Blood Pressure Goals Could Prevent Millions of CVD Events

Mortality Outcomes Similar Whether TAVR Performed in Hybrid OR or Cath Lab

PORTICO I: Low 1-Year Mortality With Repositionable TAVR Valve in OUS Experience

Advertisement

Advertisement

Sign In

Forgot Your Password?

Search TCTMD

CME TITLE

Sign up for our newsletter

Search TCTMD

Submit an Event

Become a PREMIUM MEMBER or LOG IN to view exclusive content

REGISTER for free or LOG IN to view this content